Suchergebnisse - "Han, Liz Y"

PubPharm (59)

1

Author Correction : Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

enthalten in: Nature medicine | 2021

von Thaker, P. | Han, L. | Kamat, A. | +24

ErratumFor: Nat Med. 2006 Aug;12(8):939-44. - PMID 16862152

2

Correction : Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Halder, J. | Kamat, A. | Landen, C. | +12

ErratumFor: Clin Cancer Res. 2006 Aug 15;12(16):4916-24. - PMID 16914580

3

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

enthalten in: Journal of the National Cancer Institute | 2013

von Merritt, W. | Lin, Y. | Spannuth, W. | +13

4

Efficacy and Antivascular Effects of EphA2 Reduction With an Agonistic Antibody in Ovarian Cancer

enthalten in: Journal of the National Cancer Institute | 2013

von Landen, C. | Lu, C. | Han, L. | +16

5

Src activation by β-adrenoreceptors is a key switch for tumour metastasis

enthalten in: Nature communications | 2013

von Armaiz-Pena, G. | Allen, J. | Cruz, A. | +31

ErratumIn: Nat Commun. 2013;4:1932 Shazhad, Mian M K [corrected to Shahzad, Mian M K]

6

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

enthalten in: Cancer biology & therapy | 2010

von Merritt, W. | Kamat, A. | Hwang, J. | +16

7

Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy

enthalten in: European journal of cancer (Oxford, England : 1990) | 2010

von Han, L. | Karavasilis, V. | Hagen, T. | +8

8

Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis

enthalten in: The Journal of clinical investigation | 2010

von Sood, A. | Armaiz-Pena, G. | Halder, J. | +21

9

Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy

enthalten in: The European journal of cancer / A | 2010

von Han, L. | Karavasilis, V. | Hagen, T. | +8

10

Plasma cell-free DNA in ovarian cancer : an independent prognostic biomarker

enthalten in: Cancer | 2010

von Kamat, A. | Baldwin, M. | Urbauer, D. | +9

1
2
3
4
5
6
Nächster »
[6]